ANGO
Income statement / Annual
Last year (2024), AngioDynamics, Inc.'s total revenue was $303.91 M,
a decrease of 10.28% from the previous year.
In 2024, AngioDynamics, Inc.'s net income was -$184.35 M.
See AngioDynamics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
05/31/2024 |
05/31/2023 |
05/31/2022 |
05/31/2021 |
05/31/2020 |
05/31/2019 |
05/31/2018 |
05/31/2017 |
05/31/2016 |
05/31/2015 |
| Operating Revenue |
$303.91 M
|
$338.75 M
|
$316.22 M
|
$291.01 M
|
$264.16 M
|
$359.48 M
|
$344.29 M
|
$349.64 M
|
$353.69 M
|
$356.97 M
|
| Cost of Revenue |
$149.22 M |
$164.51 M |
$150.49 M |
$134.22 M |
$113.89 M |
$167.61 M |
$167.41 M |
$173.47 M |
$179.72 M |
$180.09 M |
| Gross Profit |
$154.70 M |
$174.25 M |
$165.73 M |
$156.79 M |
$150.27 M |
$191.87 M |
$176.88 M |
$176.17 M |
$173.97 M |
$176.89 M |
| Gross Profit Ratio |
0.51 |
0.51 |
0.52 |
0.54 |
0.57 |
0.53 |
0.51 |
0.5 |
0.49 |
0.5 |
| Research and Development
Expenses |
$31.51 M
|
$29.88 M
|
$30.74 M
|
$36.39 M
|
$29.68 M
|
$29.44 M
|
$25.46 M
|
$25.27 M
|
$25.13 M
|
$26.93 M
|
| General & Administrative
Expenses |
$41.16 M
|
$40.00 M
|
$38.45 M
|
$35.92 M
|
$37.87 M
|
$35.17 M
|
$31.27 M
|
$31.41 M
|
$29.21 M
|
$29.87 M
|
| Selling & Marketing
Expenses |
$102.82 M
|
$104.25 M
|
$95.30 M
|
$81.31 M
|
$78.63 M
|
$80.96 M
|
$77.28 M
|
$78.82 M
|
$84.91 M
|
$80.62 M
|
| Selling, General &
Administrative Expenses |
$143.98 M
|
$144.25 M
|
$133.75 M
|
$117.22 M
|
$116.51 M
|
$116.13 M
|
$108.54 M
|
$110.23 M
|
$114.12 M
|
$110.49 M
|
| Other Expenses |
$171.64 M |
$18.79 M |
$19.46 M |
$18.14 M |
$18.12 M |
$19.77 M |
-$31,000.00 |
-$3.12 M |
-$5.01 M |
-$7.01 M |
| Operating Expenses |
$347.13 M |
$192.93 M |
$183.95 M |
$171.75 M |
$164.31 M |
$165.34 M |
$150.64 M |
$150.95 M |
$159.78 M |
$159.48 M |
| Cost And Expenses |
$496.35 M |
$357.43 M |
$334.44 M |
$305.97 M |
$278.19 M |
$332.95 M |
$318.05 M |
$324.43 M |
$339.50 M |
$339.56 M |
| Interest Income |
$0.00 |
$2.70 M |
$688,000.00 |
$861,000.00 |
$907,000.00 |
$5.10 M |
$0.00 |
$0.00 |
$11,000.00 |
$4,000.00 |
| Interest Expense |
$0.00 |
$2.70 M |
$688,000.00 |
$861,000.00 |
$907,000.00 |
$5.10 M |
$3.06 M |
$2.84 M |
$3.40 M |
$3.20 M |
| Depreciation &
Amortization |
$27.71 M
|
$33.17 M
|
$29.50 M
|
$26.29 M
|
$23.49 M
|
$20.16 M
|
$17.31 M
|
$23.30 M
|
$26.16 M
|
$30.49 M
|
| EBITDA |
-$14.29 M
|
$12.19 M
|
$11.13 M
|
-$8.90 M
|
-$143.74 M
|
$10.55 M
|
$3.11 M
|
$12.97 M
|
$26.30 M
|
$22.91 M
|
| EBITDA Ratio |
-0.05 |
0.03 |
0.03 |
0.04 |
0.04 |
0.27 |
0.14 |
0.17 |
0.16 |
0.19 |
| Operating Income Ratio
|
-0.63
|
-0.06
|
-0.06
|
-0.05
|
-0.05
|
0.06
|
0.03
|
0.04
|
0
|
-0
|
| Total Other
Income/Expenses Net |
$797,000.00
|
-$35.20 M
|
-$1.48 M
|
-$4.50 M
|
-$1.04 M
|
-$5.31 M
|
-$3.09 M
|
-$27.26 M
|
-$4.27 M
|
-$4.55 M
|
| Income Before Tax |
-$191.64 M |
-$54.44 M |
-$29.95 M |
-$36.05 M |
-$167.14 M |
$59.47 M |
$7.47 M |
$11.85 M |
-$4.36 M |
-$8.00 M |
| Income Before Tax Ratio
|
-0.63
|
-0.16
|
-0.09
|
-0.12
|
-0.63
|
0.17
|
0.02
|
0.03
|
-0.01
|
-0.02
|
| Income Tax Expense |
-$7.29 M |
-$2.00 M |
-$3.40 M |
-$4.50 M |
-$1.35 M |
-$1.87 M |
-$8.87 M |
$4.84 M |
$40.10 M |
-$4.73 M |
| Net Income |
-$184.35 M |
-$52.44 M |
-$26.55 M |
-$31.55 M |
-$165.79 M |
$61.34 M |
$16.34 M |
$7.01 M |
-$44.45 M |
-$3.27 M |
| Net Income Ratio |
-0.61 |
-0.15 |
-0.08 |
-0.11 |
-0.63 |
0.17 |
0.05 |
0.02 |
-0.13 |
-0.01 |
| EPS |
-4.59 |
-1.33 |
-0.68 |
-0.82 |
-4.37 |
1.64 |
0.44 |
0.19 |
-1.23 |
-0.0916 |
| EPS Diluted |
-4.59 |
-1.33 |
-0.68 |
-0.82 |
-4.37 |
1.64 |
0.44 |
0.19 |
-1.23 |
-0.0916 |
| Weighted Average Shares
Out |
$40.18 M
|
$39.48 M
|
$39.01 M
|
$38.34 M
|
$37.96 M
|
$37.48 M
|
$37.08 M
|
$36.62 M
|
$36.02 M
|
$35.68 M
|
| Weighted Average Shares
Out Diluted |
$40.18 M
|
$39.48 M
|
$39.01 M
|
$38.34 M
|
$37.96 M
|
$37.48 M
|
$37.54 M
|
$36.96 M
|
$36.16 M
|
$35.68 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
